Summary Cellular DNA content of primary tumours from 280 patients with operable breast cancer was determined by flow cytometry using nuclei from paraffin sections stained with DAPI, and 199 of these patients were followed for 8-13 years after surgery. Tumours from 67 patients have also been analyzed for their DNA content using single cell suspensions from fresh tumour tissue stained with mithramycin and ethidium bromide, and the results compared with those obtained from paraffin blocks of the same tumours.
The DNA content of the cells in a tumour is becoming a frequently measured tumour characteristic. It is a feature which is variable between tumours of a given site (Atkin & Richards, 1956) , and as it involves evaluation of a degree of abnormality in the genetically heritable components of the cell, might be expected to relate to the biological behaviour of the tumour. However, the significance of this putative relationship between abnormal DNA content and biological behaviour with respect to the clinical outcome with different types of tumour is still not fully established.
Many studies have shown significant correlations in breast cancer between cellular DNA content and other clinical and pathological features of the tumour suggestive of poor clinical outcome for patients with DNA-aneuploid tumours (see e.g. Olszewski et al., 1981; Fossa et al., 1982; Raber et al., 1982; Taylor et al., 1983; Auer et al., 1984; Hedley et al., 1985; Thorud et al., 1986) . A few studies have shown a significant difference in the survival of patients with diploid and aneuploid tumours (Atkin 1972 ; Atkin & Kay 1979; Auer et al., 1980; and in the disease-free interval (Auer et al., 1984; Ewers et al., 1984; Hedley et al., 1984; . However, studies in other centres have not found such correlations or the correlations did not reach statistical significance (Raber et al., 1982; Taylor et al., 1983; Coulson et al., 1984; Stuart-Harris et al., 1985) . Therefore, the significance of the presence of a cell population with abnormal DNA content in breast cancer has not been fully resolved. More work is needed to define the influence of this tumour characteristic on patient survival, and its relationship to other features and properties of the tumour of known prognostic significance. This paper describes our investigations into the determination of cellular DNA Flow cytometry Flow analysis was done using FACS IV (Becton Dickinson FACS system). DAPI fluorescence was excited using 40mW UV light from an argon laser and collected via a 488 band pass filter with a 10nM bandwidth. The mean coefficient of variation of the GO/GI peak was 6.6% (range 4.9-8.7). Mithramycin fluorescence was excited using 120mW light at 457nM from an argon laser and fluorescence collected via 520 long pass filters.
DNA index (DI) was determined according to a recently suggested convention on nomenclature for DNA cytometry (Hiddemann et al., 1984) . Thus DI was defined as the ratio of the mode of the relative DNA content of the GO/GI cells of the sample divided by the mode of the relative DNA measurement of the diploid GO/GI reference cells. Cells with a normal diploid karyotype have, by definition a DI of 1.0 (Figure la) . A DNA histogram was said to contain a DNAaneuploid population when at least two separate GO/GI peaks were demonstrable ( Figure lc) and DI greater or lower than 1.0. Where the putative aneuploid peak was at or near the G2 position (DI 1.9-2.1), an arbitary cut-off point was used, so that peaks containing more than 15% of the cells in the distribution were defined as DNA-aneuploid.
Normal human lymphocytes were stained by the same procedure with each batch of fresh tumours analysed and run before the samples to calibrate the instrument for the position of GO/GI normal DNA-diploid peak. Each tumour sample is a suspension of normal and malignant cells and the normal cells in the tumour sample, identified by the position of their peak on the same channel of the prerun normal lymphocytes, were used as internal diploid standard for DI calculation.
For the paraffin embedded samples no internal standard, apart from the normal cells within the tumour sample, was used as neither chicken RBC nor human peripheral lymphocytes give consistent ratios to the diploid peak when added to the pepsin digests of embedded tissue (Hedley et al., 1983) . Therefore, the first peak in the histogram was considered as GO/GI normal diploid standard.
For the purposes of comparison of data from fresh and paraffin sections, the DI for the tumours found to be hypodiploid in the' analysis of fresh tissue were recalculated assuming the first peak to be diploid, as is done for the paraffin sections.
Histological grading Histological assessment was done by a modification of the method of Bloom and Richardson, 1957 (Elston et al., 1982) .
Tumours are graded on a scale from grade I (well differentiated), to grade III (poorly differentiated), using a scoring system which takes into account tubule formation, nuclear pleomorphism, and mitotic activity.
Oestrogen receptors assay
The assays have been performed by Tenovus institute (Cardiff) by the dextran coated charcoal method (Nicholson et al., 1981 (Figure 4) . DNA-aneuploid tumours, however, were more likely to recur in the first 2 years following the removal of the primary tumour, than DNA-diploid tumours (Table I) Time (months) Figure 5 Survival of patients with DNA-diploid (-) and DNA- aneuploid (0) DNA-diploid tumours in several studies (Atkin, 1972; Auer et al., 1980; . When tetraploid tumours were excluded from our analysis, there was still no significant difference in the survival of patients with DNA-aneuploid and DNAdiploid tumours.
Relationship between DNA ploidy and histological grade DNA ploidy was strongly related to the histological grade of differentiation of the tumours (P<0.0001; Table II ). Thus well differentiated tumours were predominantly DNAdiploid (78%) whilst the poorly differentiated tumours were mostly DNA-aneuploid (74%). In view of the strong prognostic significance of histological grade , and the weakness of the relationship between ploidy and survival shown above, it is surprising that such a strong correlation is observed between ploidy and grade. Furthermore, detailed analysis shows that DNA-aneuploidy tends to be associated with better survival in patients with grade I and II tumours (Figure 6a, b) . This relationship was significant with grade II (P<0.01). No difference in overall survival between patients with DNA-aneuploid and DNAdiploid tumours was observed in grade III patients (Figure 6c ). (Table IV) . Relationship between DNA ploidy and prognostic grouping Grouping the patients according to the prognostically significant pathological features (Nottingham prognostic index), showed significant difference in the distribution of These data show that there is a complex relationship between tumour DNA ploidy and patient survival. Thus, DNA-aneuploidy correlates significantly with other features known to be associated with poor prognosis in breast cancer, including poor histological grade and lower levels of oestrogen receptors, as has been found by others (for e.g., Fossa et al., 1982; Olszewski et al., 1981; Raber et al., 1982; Taylor et al., 1983; Hedley et al., 1984 (Ewers et al., 1984; Hedley et al., 1984; Thorud et al., 1986) , and is consistent with the findings of others who take two different time points of follow up to reflect the disease free survival significance of DNA ploidy (Auer et al., 1984) . Survival after recurrence was not different whether the tumour was DNA-diploid or DNA-aneuploid, in agreement with the observation of Stuart-Harris et al., (1985) . Also, there was no apparent relationship between response to treatment and DNA-aneuploidy. There appears to be some inconsistency between the results of studies using static cytometry (e.g. Auer et al., 1984) and flow methods. This may reflect a difference in sensitivity, as flow methods may not detect small populations of aneuploid cells which might be selected for measurement in static cytometry. However, it is clear that there are many patients whose tumours contain frank, easily detected DNA-aneuploid populations, but whose prognosis is not poor in comparison with similar patients with DNAdiploid tumours.
Another complex aspect of the relationship between DNAaneuploidy and survival is the interaction with histological grade. Thus there appears to be longer survival of patients with DNA-aneuploid tumours that are moderately differentiated (grade II), in comparison with DNA-diploid tumours of the same histological grades. A similar trend is observed for grade I patients, although there are few DNAaneuploid tumours in this group, and the difference is not significant by life table analysis. The failure of a subgroup of patients with DNA-aneuploid breast tumours to do badly in comparison to their DNA-diploid counterparts is not without precedent. For example, in a small group of patients undergoing treatment for advanced disease, Stuart-Harris et al., (1985) found a trend for patients with DNA-aneuploid tumours to survive better.
Further explanation is required for the paradox that although DNA-aneuploidy is strongly related to histological grade, and grade is strongly related to survival, DNAaneuploidy is not predictive of poor survival. One possibility is that DNA-aneuploidy correlates with an element of grade that does not strongly relate to survival. To investigate this point, comparisons have been made between DNAaneuploidy and objective measurements of nuclear features of some of the tumours in this study; the detail of these measurements will be reported separately (Ellis et al., in preparation). DNA-diploid tumours were found to be associated with smaller size nuclei with limited variations in nuclear area and perimeter and almost all DNA-diploid tumours were associated with the lowest rate of mitosis, whereas DNA-aneuploid tumours were associated with larger nuclei with a wide range of variation in nuclear area and perimeter, and contained a wide range of mitotic activity. This suggests that low proliferative activity is found in DNA-diploid tumours, in contrast to DNA-aneuploid tumours where an extended range of proliferative activity was observed. When the patients were grouped into different survival groups according to these nuclear morphometric measurements and mitotic rate, the long survival groups were predominantly DNA-diploid. DNA-aneuploid tumours were distributed over a wide range of survival, which seems to obscure the survival advantage of DNA-diploid tumours.
These studies show that DI is a marker which relates to prognostically significant features in breast cancer, and DNA-diploidy may in particular be associated with low proliferative activity. However, DI is not useful as a single marker for prediction of survival. More detailed analysis will be required to assess the possibility of using DI as a factor, with the other prognostically significant parameters, contributing to prognosis in primary breast cancer.
